First Time Loading...

Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 55.95 USD 0.25% Market Closed
Updated: Jun 13, 2024
Have any thoughts about
Catalent Inc?
Write Note

Wall Street
Price Targets

CTLT Price Targets Summary
Catalent Inc

Wall Street analysts forecast CTLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTLT is 57.83 USD with a low forecast of 42.42 USD and a high forecast of 66.68 USD.

Lowest
Price Target
42.42 USD
24% Downside
Average
Price Target
57.83 USD
3% Upside
Highest
Price Target
66.68 USD
19% Upside

CTLT Last Price Targets
Catalent Inc

The latest public price target was made on May 20, 2024 by Jacob Johnson from Stephens , who expects CTLT stock to rise by 13% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Jacob Johnson
Stephens
63.5 USD
Upside 13%
3 weeks ago
May 20, 2024
Stephens Reiterates Equal Weight Rating on Catalent (CTLT)
StreetInsider
Sean Dodge
RBC Capital
41 USD
Downside 27%
1 year ago
May 19, 2023
Catalent Likely To Report Sharp Decline In Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Benzinga
Evan Stover
Robert W. Baird
53 USD
Downside 5%
1 year ago
May 19, 2023
Catalent Likely To Report Sharp Decline In Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Benzinga
Unknown Analyst
Barclays
82 USD
Upside 47%
1 year ago
Feb 8, 2023
Barclays Maintains Overweight on Catalent, Raises Price Target to $82
Benzinga
Jacob Johnson
Stephens
Price Target 63.5 USD
Upside/Downside 13%
View Source
Sean Dodge
RBC Capital
Price Target 41 USD
Upside/Downside 27%
View Source
Evan Stover
Robert W. Baird
Price Target 53 USD
Upside/Downside 5%
View Source
Unknown Analyst
Barclays
Price Target 82 USD
Upside/Downside 47%
View Source
Catalent Inc Competitors:
Price Targets
603139
Shaanxi Kanghui Pharmaceutical Co Ltd
54% Upside
CLN
Celon Pharma SA
1% Downside
GLENMARK
Glenmark Pharmaceuticals Ltd
12% Downside
KLBF
Kalbe Farma Tbk PT
8% Upside
GSK
GlaxoSmithKline PLC
23% Upside
102940
Kolon Life Science Inc
514% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
43% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Catalent Inc

For the last 8 years the compound annual growth rate for Catalent Inc's revenue is 11%. The projected CAGR for the next 3 years is 6%.

11%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Catalent Inc

For the last 8 years the compound annual growth rate for Catalent Inc's operating income is -11%. The projected CAGR for the next 3 years is 77%.

-11%
Past Growth
77%
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Net Income
Forecast

Net Income Estimate
Catalent Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CTLT's stock price target?
Price Target
57.83 USD

According to Wall Street analysts, the average 1-year price target for CTLT is 57.83 USD with a low forecast of 42.42 USD and a high forecast of 66.68 USD.

What is Catalent Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Catalent Inc's revenue is 11%. The projected CAGR for the next 3 years is 6%.

What is Catalent Inc's Operating Income forecast?
Projected CAGR
77%

For the last 8 years the compound annual growth rate for Catalent Inc's operating income is -11%. The projected CAGR for the next 3 years is 77%.